Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Guselkumab patent expiration?
Drugpatentwatch crizotinib?
Patent expiry trametinib?
Pramlintide fda approval date?
Dabrafenib patent expiration?

Infliximab injection price?

See the DrugPatentWatch profile for Infliximab

Infliximab (Remicade®) – Injection (IV infusion) Pricing (U.S.)

Item Typical Price (2024–2025)
Base drug cost (1 mg/mL vial) $1,200–$1,500 per vial (for 5 mg/mL strength)
Average cost per infusion $1,200–$4,000 (depends on dose, weight, and number of vials used)
Typical dosing schedule 5 mg/kg at weeks 0, 2, 6, then every 8 weeks (adjustable by clinician)
Total yearly cost (≈6 infusions) $7,200–$24,000 (before insurance, rebates, or patient assistance)

What Influences the Cost?

Factor How It Affects Price
Weight‑based dosing Higher‑weight patients need more drug per infusion → higher cost.
Infusion length & monitoring Longer infusion times or additional monitoring add to overall cost.
Formulation Standard Remicade® is the original; biosimilars (e.g., Inflectra®, Renflexis®, etc.) can be 10–30 % cheaper.
Insurance & rebates Most insurers negotiate rebates; net price may be lower than list price.
Patient assistance programs Gilead’s “Patient Assistance Program” can reduce or waive copays for eligible patients.
Geographic location Hospital or infusion center pricing varies; urban centers often charge more.
Hospital vs. outpatient clinic Outpatient infusion centers sometimes offer lower per‑infusion costs due to lower overhead.

How to Find Your Exact Cost

  1. Check Your Insurance Policy – Look at the formulary and copay structure for biologic agents.
  2. Ask Your Pharmacy or Infusion Center – They can give the current list price and any applicable rebates.
  3. Use Cost‑Transparency Tools – Websites like GoodRx, HealthCost or the Centers for Medicare & Medicaid Services (CMS) Part B database provide estimated charges for IV biologics.
  4. Explore Biosimilars – If your doctor is comfortable, a biosimilar version of infliximab may reduce the cost by 10–30 %.

Quick Bottom Line

  • Infliximab infusions are expensive—often in the $1,200–$4,000 range per dose, depending on weight and dosage.
  • Annual costs can reach $15,000–$25,000 before insurance discounts.
  • Biosimilars and insurance negotiations can bring the out‑of‑pocket amount down significantly.

If you’re planning treatment or budgeting, talk with your prescribing doctor and pharmacy about the most cost‑effective options (including biosimilars) and available patient assistance programs.



Other Questions About Infliximab :

remicade (infliximab) us patent expiry date and generic entry Infliximab biosimilar list? Infliximab patent? Price of infliximab? Infliximab cost? Infliximab price? Infliximab patent expiry 2016?